**Core Concept**
In iron deficiency anemia (IDA), total iron-binding capacity (TIBC) is elevated due to increased production of transferrin, a protein that binds iron. In contrast, anemia of chronic disease (ACD) is characterized by decreased TIBC, reflecting a reduction in transferrin synthesis.

**Why the Correct Answer is Right**
In IDA, the body attempts to compensate for iron deficiency by increasing the production of transferrin, which is responsible for binding iron. This results in elevated TIBC levels. In ACD, chronic inflammation suppresses hepcidin production, leading to increased iron availability and decreased transferrin synthesis. Consequently, TIBC levels are decreased. This distinction is crucial for differentiating between these two types of anemia.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it fails to account for the decrease in TIBC seen in anemia of chronic disease.
* **Option B:** This option is incorrect because it ignores the compensatory increase in transferrin production in iron deficiency anemia.
* **Option C:** This option is incorrect because it does not accurately reflect the pathophysiology of either anemia of chronic disease or iron deficiency anemia.
* **Option D:** This option is incorrect because it is incomplete and does not address the differential effects of anemia of chronic disease and iron deficiency anemia on TIBC.

**Clinical Pearl / High-Yield Fact**
Remember the "3 Ts" to differentiate between iron deficiency anemia and anemia of chronic disease: **TIBC** is elevated in IDA, **Transferrin saturation** is low in IDA, and **Thyroid function tests** are often abnormal in ACD.

**Correct Answer:** B.